Cargando…

In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol

OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Righi, Elda, Scudeller, Luigia, Chiamenti, Margherita, Abdelraouf, Kamilia, Lodise, Thomas, Carrara, Elena, Savoldi, Alessia, Menghin, Dario, Pellizzari, Gloria, Ellis, Sally, Franceschi, Francois, Piddock, Laura, Rebuffi, Chiara, Sanguinetti, Maurizio, Tacconelli, Evelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647577/
https://www.ncbi.nlm.nih.gov/pubmed/35047691
http://dx.doi.org/10.1136/bmjos-2019-100055
_version_ 1784610633082208256
author Righi, Elda
Scudeller, Luigia
Chiamenti, Margherita
Abdelraouf, Kamilia
Lodise, Thomas
Carrara, Elena
Savoldi, Alessia
Menghin, Dario
Pellizzari, Gloria
Ellis, Sally
Franceschi, Francois
Piddock, Laura
Rebuffi, Chiara
Sanguinetti, Maurizio
Tacconelli, Evelina
author_facet Righi, Elda
Scudeller, Luigia
Chiamenti, Margherita
Abdelraouf, Kamilia
Lodise, Thomas
Carrara, Elena
Savoldi, Alessia
Menghin, Dario
Pellizzari, Gloria
Ellis, Sally
Franceschi, Francois
Piddock, Laura
Rebuffi, Chiara
Sanguinetti, Maurizio
Tacconelli, Evelina
author_sort Righi, Elda
collection PubMed
description OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to investigate in vivo effects of antibiotic combination on mortality and disease burden for infections due to CR Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacteriaceae and provide an unbiased overview of existing knowledge. The results of the study can help prioritising future research on the most promising therapies against CR bacteria. METHODS AND ANALYSIS: This protocol was formulated using the Systematic Review Protocol for Animal Intervention Studies (SYRCLE) Checklist. Publications will be collected from PubMed, Scopus, Embase and Web of Science. Quality checklists adapted by Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies and SYRCLE’s risk of bias tool will be used. If the meta-analysis seems feasible, the ES and the 95% CI will be analysed. The heterogeneity between studies will be assessed by I(2) test. Subgroup meta-analysis will be performed when possible to assess the impact of the studies on efficacy of the treatments. Funnel plotting will be used to evaluate the risk of publication bias. DISSEMINATION: This systematic review and meta-analysis is part of a wider research collaboration project, the COmbination tHErapy to treat sepsis due to carbapenem-Resistant bacteria in adult and paediatric population: EvideNCE and common practice (COHERENCE) study that includes also the analyses of in vitro and human studies. Data will be presented at international conferences and the results will be published in peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42019128104(available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128104).
format Online
Article
Text
id pubmed-8647577
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86475772022-01-18 In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol Righi, Elda Scudeller, Luigia Chiamenti, Margherita Abdelraouf, Kamilia Lodise, Thomas Carrara, Elena Savoldi, Alessia Menghin, Dario Pellizzari, Gloria Ellis, Sally Franceschi, Francois Piddock, Laura Rebuffi, Chiara Sanguinetti, Maurizio Tacconelli, Evelina BMJ Open Sci Protocol OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to investigate in vivo effects of antibiotic combination on mortality and disease burden for infections due to CR Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacteriaceae and provide an unbiased overview of existing knowledge. The results of the study can help prioritising future research on the most promising therapies against CR bacteria. METHODS AND ANALYSIS: This protocol was formulated using the Systematic Review Protocol for Animal Intervention Studies (SYRCLE) Checklist. Publications will be collected from PubMed, Scopus, Embase and Web of Science. Quality checklists adapted by Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies and SYRCLE’s risk of bias tool will be used. If the meta-analysis seems feasible, the ES and the 95% CI will be analysed. The heterogeneity between studies will be assessed by I(2) test. Subgroup meta-analysis will be performed when possible to assess the impact of the studies on efficacy of the treatments. Funnel plotting will be used to evaluate the risk of publication bias. DISSEMINATION: This systematic review and meta-analysis is part of a wider research collaboration project, the COmbination tHErapy to treat sepsis due to carbapenem-Resistant bacteria in adult and paediatric population: EvideNCE and common practice (COHERENCE) study that includes also the analyses of in vitro and human studies. Data will be presented at international conferences and the results will be published in peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42019128104(available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128104). BMJ Publishing Group 2020-07-21 /pmc/articles/PMC8647577/ /pubmed/35047691 http://dx.doi.org/10.1136/bmjos-2019-100055 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Protocol
Righi, Elda
Scudeller, Luigia
Chiamenti, Margherita
Abdelraouf, Kamilia
Lodise, Thomas
Carrara, Elena
Savoldi, Alessia
Menghin, Dario
Pellizzari, Gloria
Ellis, Sally
Franceschi, Francois
Piddock, Laura
Rebuffi, Chiara
Sanguinetti, Maurizio
Tacconelli, Evelina
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title_full In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title_fullStr In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title_full_unstemmed In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title_short In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
title_sort in vivo studies on antibiotic combination for the treatment of carbapenem-resistant gram-negative bacteria: a systematic review and meta-analysis protocol
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647577/
https://www.ncbi.nlm.nih.gov/pubmed/35047691
http://dx.doi.org/10.1136/bmjos-2019-100055
work_keys_str_mv AT righielda invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT scudellerluigia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT chiamentimargherita invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT abdelraoufkamilia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT lodisethomas invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT carraraelena invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT savoldialessia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT menghindario invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT pellizzarigloria invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT ellissally invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT franceschifrancois invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT piddocklaura invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT rebuffichiara invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT sanguinettimaurizio invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol
AT tacconellievelina invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol